Přihlásit se Zaregistrujte se zdarma

EBIT margin společnosti Akorn

Jaká je hodnota metriky EBIT margin společnosti Akorn?

Hodnota metriky EBIT margin společnosti Akorn, Inc. je -56.79%

Jaká je definice metriky EBIT margin?



EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.

ttm (trailing twelve months)

EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.

EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.

EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.

EBIT margin společností v sektoru Health Care sektor na OTC ve srovnání se společností Akorn

Čemu se věnuje společnost Akorn?

Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Firmy s metrikou ebit margin podobnou společnosti Akorn



  • Hodnota metriky EBIT margin společnosti FinLab AG je -57.24%
  • Hodnota metriky EBIT margin společnosti cbdMD je -57.14%
  • Hodnota metriky EBIT margin společnosti Cree je -57.13%
  • Hodnota metriky EBIT margin společnosti Biolife Solutions Inc je -56.85%
  • Hodnota metriky EBIT margin společnosti Mukand Engineers je -56.84%
  • Hodnota metriky EBIT margin společnosti TELA Bio je -56.79%
  • Hodnota metriky EBIT margin společnosti Akorn je -56.79%
  • Hodnota metriky EBIT margin společnosti Insilco je -56.74%
  • Hodnota metriky EBIT margin společnosti M8 Sustainable je -56.74%
  • Hodnota metriky EBIT margin společnosti Milestone Scientific je -56.58%
  • Hodnota metriky EBIT margin společnosti Cambium Networks Corp je -56.50%
  • Hodnota metriky EBIT margin společnosti Greenpro Capital je -56.40%
  • Hodnota metriky EBIT margin společnosti Greenpro Capital je -56.40%